MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
ENDRA Life Sciences ROCE Ratio 2011-2026 | NDRA
Annual ROCE Ratio ENDRA Life Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -185.74 | -281.17 | -179.81 | -173.8 | -106.62 | -147.87 | -212.47 | -139.74 | -87.69 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -87.69 | -281.17 | -168.32 |
Quarterly ROCE Ratio ENDRA Life Sciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -232.5 | -139.26 | -105.48 | -121.41 | -154.46 | -212.05 | -187.51 | -57.59 | -91.08 | -66.98 | -93.77 | -91.76 | -111.91 | -98.57 | -93.13 | -55.7 | -97.46 | -119.06 | -134.71 | -120.12 | -171.86 | -181.85 | -190.41 | -151.13 | -188.83 | -174.79 | -158.41 | -112.29 | -129.56 | -109.13 | -99.98 | -44.14 | 23.57 | 108.54 | 183.88 | 164.79 | 164.79 | 97.09 | 41.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 183.88 | -232.5 | -84.93 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.63 | -1.21 % | $ 2.17 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 114.87 | -0.65 % | $ 34.9 B | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.7 | -1.12 % | $ 686 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 21.91 | 0.27 % | $ 1.17 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 126.92 | -1.24 % | $ 20.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.3 | -1.92 % | $ 463 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 83.55 | -0.67 % | $ 5.64 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 166.79 | -2.59 % | $ 8.27 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 16.84 | -1.58 % | $ 377 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
440.3 | $ 83.09 | -6.11 % | $ 10.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.12 | -1.53 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
-8.25 | $ 31.75 | 3.42 % | $ 51 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 5.5 | -7.72 % | $ 326 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.93 | - | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.18 | -1.24 % | $ 300 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 409.65 | -2.78 % | $ 11.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Biomerica
BMRA
|
-125.14 | $ 2.19 | 0.46 % | $ 5.03 M | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 470.22 | 0.47 % | $ 177 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 102.49 | -0.7 % | $ 8.45 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 259.57 | -1.47 % | $ 21.6 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.61 | -4.93 % | $ 61.9 M | Irlanda |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.34 | -1.16 % | $ 2.03 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 120.07 | -4.46 % | $ 5.61 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 59.15 | -3.03 % | $ 3.54 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 9.02 | 4.76 % | $ 1.16 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.84 | 0.21 % | $ 448 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 200.17 | -2.06 % | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 195.05 | -0.8 % | $ 21.7 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | USA |